(Q44001864)

28 November 2017

title

Contra-indications to metformin therapy are largely disregarded (English)

1 reference

28 November 2017

1 reference

1 reference

Holstein A

1

1 reference

28 November 2017

Nahrwold D

series ordinal

2

1 reference

28 November 2017

Hinze S

series ordinal

3

1 reference

28 November 2017

Egberts EH

series ordinal

4

1 reference

28 November 2017

publication date

1 August 1999

1 reference

28 November 2017

1 reference

28 November 2017

volume

16

1 reference

28 November 2017

issue

8

1 reference

28 November 2017

page(s)

692-696

1 reference

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00115.X

Metformin's effects on glucose and lipid metabolism in patients with secondary failure to sulfonylureas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00115.X

Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00115.X

Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00115.X

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00115.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00115.X

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00115.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00115.X

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00115.X

Occurrence of diabetes mellitus in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00115.X

Incidence of and Risk Factors for Atrial Fibrillation in Older Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00115.X

Biguanide-associated lactic acidosis. Case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00115.X

Lactic acidosis rates in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00115.X

10.1046/J.1464-5491.1999.00115.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference